Company / Free Cash Flow per Share
NEKTAR THERAPEUTICS Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$16.85
FY2025
5-year range
-$16.85 / -$1.01
FY2021-FY2025
Trend
-1566.8%
vs FY2024
Sector context
#190 of 192
Health Care
What the data says
Free Cash Flow per Share changed -1567% YoY in FY2025, a notable deviation from the 9-year average annual change of -84%.
Based on SEC 10-K filings.
-16.85 in FY2025.
Declined from $-2.27 to $-16.85 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 192This company -$16.85 Sector average $3.32
▼
-607.8% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1566.8% year-over-year.
- Ranks #190 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.85 | -1566.8% |
| FY2024 | -$1.01 | +55.4% |
| FY2023 | -$2.27 | -35.8% |
| FY2022 | -$1.67 | +29.7% |
| FY2021 | -$2.37 | -159.5% |
| FY2020 | $3.99 | +868.2% |
| FY2019 | -$0.52 | +32.9% |
| FY2018 | -$0.77 | -31.6% |
| FY2017 | -$0.59 | +47.7% |
| FY2016 | -$1.12 | -74.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026